Johan Frostegård, born 1959, is a Swedish professor of medicine, [1] an inventor and a fiction and non-fiction writer. Frostegård was born in Malmö, Sweden. He studied economics in Stockholm before pursuing a degree in medicine, later specializing in internal medicine and rheumatology. He received his PhD at Karolinska Institutet in 1992 and gained tenure as a professor there in 2003. He also holds a B.A. in the history of economics. [2]The main focus of Frostegård's research is the role of the immune system in the development and treatment of cardiovascular diseases.[3]Frostegård is a co-founder of four biotech startups: Athera Biotechnologies AB, [4] Medirista AB, [5] Medirista Biotechnologies AB [6] and Annexin Pharmaceuticals AB, [7] the latter being listed on Nasdaq First North since 2017. [8]Frostegård has written five novels, four poetry collections and several popular science books, [9] centered around evolutionary perspectives on the humanities, economics and society. [10] He has also written articles for various Swedish newspapers and magazines, [11] notably opposing euthanasia.